Bionano Laboratories Announces Expansion of Diagnostic Testing Based on Optical Genome Mapping for Hematologic Malignancies
Go back to Bionano Laboratories Announces Expansion of Diagnostic Testing Based on Optical Genome Mapping for Hematologic Malignancies| (NASDAQ: BNGO) | Delayed: 1.13 -0.05 (4.24%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.18 | 52 Week High | $ | |||
| Open | $1.18 | 52 Week Low | $ | |||
| Day High | $1.18 | P/E | N/A | |||
| Day Low | $1.10 | EPS | $ | |||
| Volume | 251,891 | |||||



